Jeanne Cheung
Acentech (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, CAR-T cell therapy research, Immune cells in cancer
Most-Cited Works
- → T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition(2017)1,623 cited
- → IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6(2006)1,522 cited
- → IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T Cells(2002)1,454 cited
- → A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R(2002)1,281 cited
- → IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo(2001)1,181 cited
- → MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade(2016)715 cited
- → Role of PD-1 during effector CD8 T cell differentiation(2018)467 cited
- → PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer(2020)449 cited
- → Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice(2017)360 cited
- → Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata)(1998)76 cited